|
tbar.gif
Click
here to
submit entries
|
|
|
Avandia
Not to Blame for Trial Deaths |
February
6, 2008--GlaxoSmithKline’s beleaguered diabetes drug Avandia (rosiglitazone)
did not cause higher rates of death in a study testing ways to prevent
heart problems in high-risk diabetics, said researchers. Patients given
aggressive treatment to lower their blood sugar levels died at a higher
rate than patients given standard therapy. But the researchers said that
no drug or combination of drugs appeared to be responsible. Reuters
|
|
|
Genstruct: Patience, Persistence, and Payoff
By John Russell |
|
Finding the right business model for systems biology (SB) technology providers has been challenging — that’s hardly a new theme in biotech.
Click
here
|
|
|
